Research ArticleArticle
Cytochrome P450 Architecture and Cysteine Nucleophile Placement Impacts Raloxifene Mediated Mechanism-Based Inactivation.
Brooke M VandenBrink, John A Davis, Josh T Pearson, Robert S Foti, Larry C. Wienkers and Dan A Rock
Molecular Pharmacology August 2, 2012, mol.112.080739; DOI: https://doi.org/10.1124/mol.112.080739
Brooke M VandenBrink
Amgen Inc
John A Davis
Amgen Inc
Josh T Pearson
Amgen Inc
Robert S Foti
Amgen Inc
Larry C. Wienkers
Amgen Inc
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
Research ArticleArticle
Cytochrome P450 Architecture and Cysteine Nucleophile Placement Impacts Raloxifene Mediated Mechanism-Based Inactivation.
Brooke M VandenBrink, John A Davis, Josh T Pearson, Robert S Foti, Larry C. Wienkers and Dan A Rock
Molecular Pharmacology August 2, 2012, mol.112.080739; DOI: https://doi.org/10.1124/mol.112.080739
Research ArticleArticle
Cytochrome P450 Architecture and Cysteine Nucleophile Placement Impacts Raloxifene Mediated Mechanism-Based Inactivation.
Brooke M VandenBrink, John A Davis, Josh T Pearson, Robert S Foti, Larry C. Wienkers and Dan A Rock
Molecular Pharmacology August 2, 2012, mol.112.080739; DOI: https://doi.org/10.1124/mol.112.080739
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement